What changed
A government-funded trial will offer multi-cancer blood tests to NHS patients at about 200 GP surgeries in England. More than 20,000 people aged 45 and over with symptoms such as pain or persistent bloating may take part in the STRIDE-RCT trial, which will test for cancers including bowel, stomach, pancreatic, liver, ovarian, kidney, bladder and prostate cancer.
Patients will give one or two blood tubes alongside routine tests. Scientists will look for proteins or DNA fragments that might signal cancer and help doctors decide who needs further investigation.
Why it matters
Hard-to-diagnose abdominal cancers are often found only after they have spread. A simple blood test could give GPs a better way to sort vague symptoms that might otherwise point to something less serious.
But this is a test of the test, not a new all-clear service. A positive result would not confirm cancer, and a negative result would not guarantee that someone is cancer-free. The trial must show whether the tests are accurate enough for wider NHS use, and whether finding cancers earlier actually reduces late-stage diagnoses or improves survival.
That caution matters because a separate NHS trial of the Galleri blood test did not meet its main goal of reducing late-stage cancer diagnoses. The STRIDE-RCT trial is therefore asking a practical question: can these tests help doctors decide who needs urgent investigation sooner, without sending too many people into unnecessary alarm and follow-up?
Comments
No comments yet.